ConductScience.org, home
Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
API referenceFor AI assistants

Trial · NCT02160782

Participant flow60

How many started, completed or left each group, period by period.

21 to 40 of 60

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Randomized Withdrawal Period- Pbo vs MRXCOMPLETEDOpen-label Period: Maralixibat (LUM001)0
Randomized Withdrawal Period- Pbo vs MRXCOMPLETEDRandomized Withdrawal Period: MRX13
Randomized Withdrawal Period- Pbo vs MRXCOMPLETEDRandomized Withdrawal Period: Placebo16
Randomized Withdrawal Period- Pbo vs MRXCOMPLETEDAfter Randomized Withdrawal Period: Maralixibat0
Randomized Withdrawal Period- Pbo vs MRXCOMPLETEDLong-term Extension Period: Maralixibat0
Randomized Withdrawal Period- Pbo vs MRXNOT COMPLETEDOpen-label Period: Maralixibat (LUM001)0
Randomized Withdrawal Period- Pbo vs MRXNOT COMPLETEDRandomized Withdrawal Period: MRX0
Randomized Withdrawal Period- Pbo vs MRXNOT COMPLETEDRandomized Withdrawal Period: Placebo0
Randomized Withdrawal Period- Pbo vs MRXNOT COMPLETEDAfter Randomized Withdrawal Period: Maralixibat0
Randomized Withdrawal Period- Pbo vs MRXNOT COMPLETEDLong-term Extension Period: Maralixibat0
After Randomized Withdrawal: MaralixibatSTARTEDOpen-label Period: Maralixibat (LUM001)0
After Randomized Withdrawal: MaralixibatSTARTEDRandomized Withdrawal Period: MRX0
After Randomized Withdrawal: MaralixibatSTARTEDRandomized Withdrawal Period: Placebo0
After Randomized Withdrawal: MaralixibatSTARTEDAfter Randomized Withdrawal Period: Maralixibat29
After Randomized Withdrawal: MaralixibatSTARTEDLong-term Extension Period: Maralixibat0
After Randomized Withdrawal: MaralixibatCOMPLETEDOpen-label Period: Maralixibat (LUM001)0
After Randomized Withdrawal: MaralixibatCOMPLETEDRandomized Withdrawal Period: MRX0
After Randomized Withdrawal: MaralixibatCOMPLETEDRandomized Withdrawal Period: Placebo0
After Randomized Withdrawal: MaralixibatCOMPLETEDAfter Randomized Withdrawal Period: Maralixibat23
After Randomized Withdrawal: MaralixibatCOMPLETEDLong-term Extension Period: Maralixibat0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02160782/flow?page=2

API referenceFor AI assistants